E-rosette-forming cells at 29°C: an assay for the evaluation of the immune status of cancer patients
- 1 November 1978
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 38 (5) , 606-611
- https://doi.org/10.1038/bjc.1978.256
Abstract
High-affinity rosette-forming T-cell assays were performed by incubation of peripheral-blood mononuclear cells with sheep erythrocytes (E) at 29 degrees C. As compared with normal controls, the levels of high-affinity rosette-forming cells (RFC) were much more frequently depressed in cancer patients than were the total E-RFC incubated at 4 degrees C. Only 2/83 normal controls had less than 38% 29 degrees C E-RFC (mean 48 +/- 5), whilst 78/89 cancer patients were below this level. The few postoperative patients tested exhibited a normal range of 29 degrees C E-RFC. The 29 degrees C E-rosette assay gives reproducible counts of a T-cell subset, and is a sensitive assay for evaluating the immune status of cancer patients.Keywords
This publication has 19 references indexed in Scilit:
- Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patientsInternational Journal of Cancer, 1978
- Importance of methodology in demonstrating depression of T-lymphocyte levelsBritish Journal of Cancer, 1978
- DEMONSTRATION OF NONSPECIFIC SUPPRESSOR CELLS IN PERIPHERAL LYMPHOCYTES OF CANCER-PATIENTS1978
- LOW AFFINITY E-ROSETTE FORMATION BY HUMAN K-CELL1978
- Human T Lymphocyte Subpopulations: Correlation Between E-Rosette-Forming Affinity and Expression of the Fc ReceptorThe Journal of Immunology, 1977
- Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: The role of suppressor cellsInternational Journal of Cancer, 1977
- T AND B LYMPHOCYTES IN BREAST CANCER STAGE RELATIONSHIP AND ABROGATION OF T-LYMPHOCYTE DEPRESSION BY ENZYME TREATMENT IN VITROThe Lancet, 1976
- Cell-Mediated Immune Status of Breast Cancer Patients: Evaluation by Skin Tests, Lymphocyte Stimulation, and Counts of Rosette-Forming Cells23JNCI Journal of the National Cancer Institute, 1974
- New formulation of digoxin.1972
- Crohn's disease and carcinoma of colon.BMJ, 1968